tradingkey.logo
tradingkey.logo
Search

GE Healthcare Technologies Inc

GEHC
Add to Watchlist
63.470USD
+2.130+3.47%
Close 05/08, 16:00ETQuotes delayed by 15 min
28.87BMarket Cap
15.15P/E TTM

GE Healthcare Technologies Inc

63.470
+2.130+3.47%
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+3.47%

5 Days

+4.00%

1 Month

-12.95%

6 Months

-13.11%

Year to Date

-22.62%

1 Year

-9.16%

Key Insights

GE Healthcare Technologies Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 20 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 81.98.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

GE Healthcare Technologies Inc's Score

Industry at a Glance

Industry Ranking
20 / 206
Overall Ranking
92 / 4494
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive+

GE Healthcare Technologies Inc Highlights

StrengthsRisks
GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 20.62B.
Undervalued
The company’s latest PE is 15.15, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 425.78M shares, decreasing 1.86% quarter-over-quarter.
Held by Nelson Peltz
Star Investor Nelson Peltz holds 4.04K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.10.

Analyst Rating

Based on 22 analysts
Buy
Current Rating
81.976
Target Price
+33.64%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

GE Healthcare Technologies Inc Info

GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
Ticker SymbolGEHC
CompanyGE Healthcare Technologies Inc
CEOBankes (Jeannette)
Websitehttps://www.gehealthcare.com
KeyAI